Company: APXIF
Filing Date: 2025-07-03
Form Type: F-4/A
Source: 0001213900-25-061545
Chunk: 417

Company: APx Acquisition Corp. I
Filing Date: 2025-07-03
Form: F-4/A
Chunk 417
---
 is also attributable to the higher share of revenues coming from Rewell, while Rewell sales expanded during the period, its impact on cost of revenues was not material, given its relatively limited scale compared to the Diagnostics segment. The increase was primarily driven by the following factors: • Increase in Salaries and Severance Costs Due to Restructuring:The Company implemented a salary increase for laboratory staff and analysts, which contributed to higher labor costs. Additionally, severance payments were made as part of the restructuring process, further increasing personnel -relatedexpenses during the period. • Higher Prices from International and Local Suppliers of Laboratory Materials, Primarily Rea gents:The Company experienced price increases from both local and international suppliers, particularly for laboratory reagents. This was driven by rising global demand, supply chain disruptions, and inflationary pressures, which significantly raised the cost of raw materials per test. • Rising Maintenance Costs for Equipment:The cost of maintaining laboratory equipment, especially related to preventive maintenance, increased due to inflation and rising service fees. These higher maintenance costs added to the overall cost of revenues, impacting profitability during the period. • Operational Inefficiencies due to Laboratory Restructuring and Equipment Transition:As part of the Company’s ongoing transition from the Illumina NextSeq 500 platform to the NextSeq 2000 system, some temporary inefficiencies emerged. These inefficiencies included overlapping quality control steps, personnel retraining, and downtime for installation, all of which contributed to higher average costs per test. However, these changes are expected to reduce costs in the future by improving laboratory efficiency and throughput. Selling expenses Selling expenses increased by $16,712, or 12.3%, from $135,697 for the six months ended December 31, 2023, to $152,409 for the six months ended December 31, 2024. This increase was primarily attributed to higher salaries for marketing employees during the period, as well as professional services contracted for marketing activities related to Rewell. 214 General and administrative expenses General and administrative expenses increased by $438,698, or 239.6%, from $183,085 for the six months ended December 31, 2023, to $621,783 for the six months ended December 31, 2024. This significant increase was primarily driven by two factors: •a higher share -basedpayment charge amounting to approximately $174,920, allocated to the CEO and three key employees, reflecting equity incentives granted during the period. •the remaining increase of approximately $263,778